Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.2460
-0.0340 (-13.82%)
Sep 5, 2025, 5:00 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 18.35 million as of September 5, 2025. Its market cap has decreased by -51.59% in one year.
Market Cap
18.35M
Enterprise Value
16.97M
Revenue
10.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 18.35M, a decrease of -81.06%. That is a compound annual growth rate of -27.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 18.35M | -25.17% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | 163.08M | 68.35% |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,592.75B |
| Coloplast | 137.26B |
| Genmab | 101.61B |
| Demant | 50.78B |
| ALK-Abelló | 44.72B |
| H. Lundbeck | 38.42B |
| Zealand Pharma | 31.27B |
| Ambu A/S | 25.47B |